CEFEPIME HYDROCHLORIDE AND DEXTROSE

B. Braun Medical Inc.🇺🇸 United States

FDA Page

Effective Date: Mar 18, 2022
Approval ID: 57517a0e-ec1b-4605-a7cc-7e3801158ec9
Products: 2 registered
Version: 23

Regulatory Information

Labeling Type

HUMAN PRESCRIPTION DRUG LABEL

Status

Approved

Full Title

These highlights do not include all the information needed to use CEFEPIME FOR INJECTION AND DEXTROSE INJECTION safely and effectively. See full prescribing information for CEFEPIME FOR INJECTION AND DEXTROSE INJECTION. CEFEPIME for injection and DEXTROSE injection, for intravenous useInitial U.S. Approval: 1996

Quick Stats

Total Products2

Labelers2

Label Sections21

Regulatory Agency

🇺🇸

U.S. Food and Drug Administration

United States

Data Sources & Disclaimer: Approval information is sourced from official FDA databases. This content is for informational purposes only and does not constitute medical or regulatory advice. Always refer to official FDA websites for the most current information.